Oncompass

Invested

2012

Founders

István Peták, Richárd Scwab

Investors

Oncompass is a precision oncology company developing molecular diagnostics and AI-driven decision support solutions that help oncologists select the most effective, personalized treatment options for cancer patients. By combining genetic testing with advanced algorithms and clinical evidence, its platform enables data-driven therapy selection tailored to each patient’s unique tumor profile. Portfolion invested in Oncompass in 2012 and exited the investment in 2020.

Related stories

Read about the most decisive moments of our life.